Results 61 to 70 of about 13,488 (162)
A New Runic Inscription from Sockburn Hall, County Durham: E 19 Sockburn
Eleanor Rye
doaj +1 more source
The inhibitory surface receptor programmed cell death protein 1 (PD1) is a major target for antibody-based cancer immunotherapies. Nevertheless, a substantial number of patients fail to respond to the treatment or experience adverse effects.
Décaillet, C. +10 more
core +1 more source
Niehr Thomas
doaj +1 more source
Anti-EGFR plus anti-PD1 in advanced and refractory cutaneous squamous cell carcinoma: a cohort study. [PDF]
Guy C +6 more
europepmc +1 more source
Biochemical identification and characterization of PD1 signaling components
In the tumor microenvironment many strategies are at work to dampen T cell activation, allowing tumor immune escape. Among these, there is the stimulation of the co-inhibitory receptor PD1 on T cells by its ligand, PDL1, which is expressed on tumor cells.
Podavini, Silvia
core
Vilmos Ágel & Mathilde Hennig (Hg.). Nähe und Distanz im Kontext variationslinguistischer Forschung
Seifert Jan
doaj +1 more source
Real-life follow-up after discontinuation of anti-PD1 therapy for complete-response cutaneous squamous cell carcinoma in patients over 75 years of age. [PDF]
Lardenois J +5 more
europepmc +1 more source
Gerdes Jens
doaj +1 more source
Spitzmüller Jürgen
doaj +1 more source
A single-institution study evaluating the fertility of young adults with malignancy treated with immunotherapy. [PDF]
Gong JD +5 more
europepmc +1 more source

